Don't Automatically Substitute Remsima or Inflectra for Remicade

You'll soon see two new infliximab meds, Remsima (REM-see-muh) and Inflectra (in-FLEC-truh).

They will be used as alternatives to Remicade...but they're NOT considered generics. Instead, they're called "biosimilars"...or "subsequent entry biologics" (SEBs).

That's because infliximab and other biologics are made from cells of living organisms and cannot be exactly duplicated.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote